Carcinoma News and Research

RSS
Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.
FDA grants Priority Review designation to sNDA for Nexavar tablets

FDA grants Priority Review designation to sNDA for Nexavar tablets

Tips from experts can help cancer survivors continue pre-diagnosis daily routines

Tips from experts can help cancer survivors continue pre-diagnosis daily routines

Bioactive compounds in coffee may prevent prostate cancer recurrence, delay progression

Bioactive compounds in coffee may prevent prostate cancer recurrence, delay progression

Study compares spectrum of cancer-related gene mutations in two common types of cervical cancer

Study compares spectrum of cancer-related gene mutations in two common types of cervical cancer

Drug to treat blood cancers may also stop spread of invasive breast cancer

Drug to treat blood cancers may also stop spread of invasive breast cancer

FDA grants Orphan Drug Designation to ADXS-HPV for treatment of HPV-associated anal cancer

FDA grants Orphan Drug Designation to ADXS-HPV for treatment of HPV-associated anal cancer

Secondary cancers in melanoma patients treated for BRAF gene mutation require new strategies

Secondary cancers in melanoma patients treated for BRAF gene mutation require new strategies

Affymetrix introduces new OncoScan FFPE Assay Kit

Affymetrix introduces new OncoScan FFPE Assay Kit

Viewpoints: Health law rollout needs a better salesman; the overhaul is shifting the economy to part-timers

Viewpoints: Health law rollout needs a better salesman; the overhaul is shifting the economy to part-timers

ImmunoGen announces FDA approval of IMGN289 Investigational New Drug

ImmunoGen announces FDA approval of IMGN289 Investigational New Drug

Omega-3 fatty acids can be used for treatment, prevention of skin and oral cancers: Research

Omega-3 fatty acids can be used for treatment, prevention of skin and oral cancers: Research

NCI experts suggest sweeping changes in approach to cancer detection, treatment

NCI experts suggest sweeping changes in approach to cancer detection, treatment

Surgery may not be necessary for women with abnormal breast tissue

Surgery may not be necessary for women with abnormal breast tissue

Adaptimmune initiates Phase I/IIa open-label clinical trial in patients with ovarian cancer

Adaptimmune initiates Phase I/IIa open-label clinical trial in patients with ovarian cancer

New data questions surgical options for treating kidney cancer

New data questions surgical options for treating kidney cancer

Research team receives NCI grant to develop precision therapies that kill cancer cells

Research team receives NCI grant to develop precision therapies that kill cancer cells

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Scientists develop histology expression predictor for most common types of lung cancer

Scientists develop histology expression predictor for most common types of lung cancer

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Phase III study: REVLIMID meets primary endpoint in patients newly diagnosed with multiple myeloma

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer: an interview with Dr. Stephen Williams of St. Joseph Hospital in Orange

Robotic retroperitoneal lymph node dissection (RPLND) for testicular cancer: an interview with Dr. Stephen Williams of St. Joseph Hospital in Orange

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.